Distinct chemokine receptor and cytokine expression profile in secondary progressive MSSØRENSEN, Torben L; SELLEBJERG, Finn.Neurology. 2001, Vol 57, Num 8, pp 1371-1376, issn 0028-3878Article

Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody productionHEDEGAARD, Chris J; SELLEBJERG, Finn; KRAKAUER, Martin et al.Multiple sclerosis. 2011, Vol 17, Num 5, pp 567-577, issn 1352-4585, 11 p.Article

Prediction of antibody persistency from antibody titres to natalizumabJENSEN, Poul Erik H; KOCH-HENRIKSEN, Nils; SELLEBJERG, Finn et al.Multiple sclerosis. 2012, Vol 18, Num 10, pp 1493-1499, issn 1352-4585, 7 p.Article

Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumabBLINKENBERG, Morten; SELLEBJERG, Finn; LEFFERS, Anne-Mette et al.Multiple sclerosis. 2013, Vol 19, Num 9, pp 1226-1229, issn 1352-4585, 4 p.Article

Differential microRNA expression in blood in multiple sclerosisSØNDERGAARD, Helle Bach; HESSE, Dan; KRAKAUER, Martin et al.Multiple sclerosis. 2013, Vol 19, Num 14, pp 1849-1857, issn 1352-4585, 9 p.Article

Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosisBÖRNSEN, Lars; KHADEMI, Mohsen; OLSSON, Tomas et al.Multiple sclerosis. 2011, Vol 17, Num 1, pp 32-42, issn 1352-4585, 11 p.Article

Cerebrospinal fluid CXCLI3 in multiple sclerosis: a suggestive prognostic marker for the disease courseKHADEMI, Mohsen; KOCKUM, Ingrid; ANDERSSON, Magnus L et al.Multiple sclerosis. 2011, Vol 17, Num 3, pp 335-343, issn 1352-4585, 9 p.Article

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosisCHRISTENSEN, Jeppe Romme; BÖRNSEN, Lars; KHADEMI, Mohsen et al.Multiple sclerosis. 2013, Vol 19, Num 7, pp 877-884, issn 1352-4585, 8 p.Article

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis : a multicentre, randomised, double-blind, placebo-controlled phase lib study. CommentarySORENSEN, Per Soelberg; SELLEBJERG, Finn; YOUSRY, Tarek A et al.Lancet (British edition). 2008, Vol 372, Num 9648, issn 0140-6736, 1447-1448, 1463-1472 [12 p.]Article

Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trialCHRISTENSEN, Jeppe Romme; RATZER, Rikke; BÖRNSEN, Lars et al.Neurology. 2014, Vol 82, Num 17, pp 1499-1507, issn 0028-3878, 9 p.Article

The effect of β-interferon therapy on myelin basic protein-elicited CD4+ Tcell proliferation and cytokine production in multiple sclerosisHEDEGAARD, Chris J; KRAKAUER, Martin; BENDTZEN, Klaus et al.Clinical immunology (Orlando, Fla. Print). 2008, Vol 129, Num 1, pp 80-89, issn 1521-6616, 10 p.Article

Neutralising antibodies to interferon β in multiple sclerosis : Expert panel reportHARTUNG, Hans-Peter; POLMAN, Chris; KILLESTEIN, Joep et al.Journal of neurology. 2007, Vol 254, Num 7, pp 827-837, issn 0340-5354, 11 p.Article

Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655SØNDERGAARD, Helle Bach; SELLEBJERG, Finn; ROMME CHRISTENSEN, Jeppe et al.European journal of human genetics. 2011, Vol 19, Num 10, pp 1100-1103, issn 1018-4813, 4 p.Article

A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosisMERO, Inger-Lise; LORENTZEN, Aslaug R; KOCKUM, Ingrid et al.European journal of human genetics. 2010, Vol 18, Num 4, pp 502-504, issn 1018-4813, 3 p.Article

Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumabSØRENSEN, Soelberg; HYLDGAARD JENSEN, Poul Erik; GOLD, Ralf et al.Multiple sclerosis. 2011, Vol 17, Num 9, pp 1074-1078, issn 1352-4585, 5 p.Article

Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis : A consensus statementFREEDMAN, Mark S; THOMPSON, Edward J; SELLEBJERG, Finn et al.Archives of neurology (Chicago). 2005, Vol 62, Num 6, pp 865-870, issn 0003-9942, 6 p.Article

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosisTREBST, Corinna; SØRENSEN, Torben Lykke; KIVISÄKK, Pia et al.The American journal of pathology. 2001, Vol 159, Num 5, pp 1701-1710, issn 0002-9440Article